A Literature Review Of Nanocarrier Development Through Emulsification Diffusion Method (Edm)
Abstract
An overview of the development of nanocarriers is presented in this work using the practical technique of the Emulsification Diffusion Method (EDM). The field of nanomedicine, which combines nanotechnology and medicine, involves creating new therapeutic and diagnostic modalities by employing precisely designed substances with this range of lengths. Many medicinal products and diagnostic tools based on nanoparticles have been developed. The emulsification-diffusion method (EDM) was utilized to prepare nanometer-sized particles, which are commonly used as polymeric carriers. The process involves emulsifying a drug and polymer solution in an aqueous phase that has been saturated with stabilizers and then adding an excessive amount of water. Investigations into how process variables affect the average size of nanoparticles have been carried out. It was made apparent that the kind and concentrations of stabilizer, the speed at which the magnetic stirrer homogenizes, and the polymer concentration all affected the size of the nanoparticles. Additionally, the medications integrated into nanocarriers have a longer half-life in circulation, which boosts their effectiveness and allows for a lower application dose. Because of their small size and high surface area, drug nanocarriers are also more bioavailable and soluble, which allows their many atoms and high surface energy to act as catalysts.
Keywords: Nanocarrier,Diffusion,Bioavailability,Solubility,Catalysts.
Full Text:
PDFReferences
Pal SL JUMPMGMR. Nanoparticle: An overview of preparation and characterization. Journal of Applied Pharmaceutical Science. 2011; 01(06): 228-234.
Fathi M BJ. Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumors. Bioimpacts. 2017; 07: 49-57.
Calzoni E CAPADMATBEC. Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies. J.Funct. Biomater. 2019; 10(4).
Hossen S HKBMMMRMUJ. Smart nanocarrier-based drug delivery systems for cancer therapy andtoxicity studies: A review. J. Adv. Res. 2019; 15: 1-18.
NM. SSS. Implications of formulation design on lipid-based. Drug Delivery. 2016;: 1306-1316.
Mario M. Modena BRTPBSW. Nanoparticle Characterization: What to Measure? Advanced Materilas. 2019 may 30; 31(32).
Cheng WW AT. The use of single chain F as targeting agents for immunoliposomes: An update on immunoliposomal drugs for cancer treatment. Expert Opin. Drug Deliv. 2010; 7: 461-478.
Bae Y JWNNFSKK. Multifunctional poly-meric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol. Biosyst. 2005; 1: 242-250.
VP T. ell penetrating peptide-modified pharmaceuticalnanocarriers for intracellular drug and gene delivery. Biopolymers. 2008; 90: 604-610.
Nataša Avramović 1 *M2SR3aS. Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy. Pharmaceutics. 2020 march 25; 12(4): 1-17.
Syed A.A. Rizvi AMS. Applications of nanoparticle systems in drug delivery technology. Saudi Pharmaceutical Journal. 2018 January; 26(1): 64-70.
Emerich DF,&TCG. Targeted nanoparticle-based drug delivery and diagnosis. Journal of Drug Targeting. 2007; 15(3): 163–183.
Groneberg DAGM, Welte TPU. Nanoparticle-Based Diagnosis and Therapy. Current Drug Targets. 2006; 7(6): 643-648.
L Zhang FGJCAWRLOF. Nanoparticles in Medicine: Therapeutic Applications and Developments. American Society for Clinical Pharmacology and Therapeutics. 2007 october 24; 83(5): 761-769.
Hye-Young Kwon a JYLaSWCaYJbJHKa. Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2001 June 30; 182(1-3): 123-130.
Quintanar-Guerrero D, de la Luz Zambrano-Zaragoza M, Gutierrez-Cortez E, Mendoza-Munoz N. Impact of the Emulsification-Diffusion Method on the Development of Pharmaceutical Nanoparticles. Recent Patents on Drug Delivery & Formulation. ; 6(3): 184-194.
Nerea Murillo-Cremaes aPSPCDaAR. Preparation and study of naproxen in silica and lipid/polymer hybrid composites. RSC Advances. 2014; 4(14): 7084-7093.
Han Mİ, Küçükgüzel ŞG. Anticancer and Antimicrobial Activities of Naproxen and Naproxen Derivatives. Mini Reviews in Medicinal Chemistry. ; 20(13): 1300-1310.
Weisman DJA&SM. Clinical Pharmacology and Cardiovascular Safety of Naproxen. American Journal of Cardiovascular Drugs. 2016 November 8; 17: 97–107.
PA. C. A Reappraisal of its Pharmacology, and Therapeutic Use in Rheumatic Diseases and Pain States. Drugs. 1990 july; 40: 91-137.
Neslihan Üstündağ Okur a ŞAbNÜKYcAYdHYKa. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations. International Journal of Pharmaceutics. 2016 February 29; 499(1-2): 228-235.
Alejandro Lapresta-Fernández PJCAJM&GJM. Fluorescent polyacrylamide nanoparticles for naproxen recognition. Analytical and Bioanalytical Chemistry. 2009 August; 395: 1821–1830.
Mello VAd, Ricci-Júnior E. Encapsulation of naproxen in nanostructured system: structural characterization and in vitro release studies. Quím. Nova. 2011; 34(6): 933-939.
Elena Ortega MARSPGRMEM. Journal of Drug Delivery Science and Technology. Journal of Drug Delivery Science and Technology. 2020 August; 58.
Kyung W. Kim a BJMb1YTKaRMKaKCaSIPc. Antimicrobial activity against foodborne pathogens of chitosan biopolymer films of different molecular weights. LWT Food science and technology. 2011; 44(2): 1362-1368.
Hassan EEM. ELEMENTAL NANOPARTICLES OF SUBSTANTIALLY WATER INSOLUBLE MATERALS. United States Patent Application Publication. 2005 Jun. 16;: 1-7.
Noriega-Peláez EK,MMN,GQA,&QGD. Optimization of the emulsification and solvent displacement method for the preparation of solid lipid nanoparticles. Drug Development and Industrial Pharmacy. 2010; 37(2): 160–166.
Refbacks
- There are currently no refbacks.
